Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 26 January 2026 to Question 106102 on Coronavirus: Research, for what reason they have yet to receive a copy of the audit; and how the scope of the recommendations can be understood without it.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The UK Health Security Agency has requested this report and continues discussions with Moderna on their response to the audit’s recommendations. This is being considered and reviewed alongside the commercial management of the Moderna-United Kingdom Strategic Partnership.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 February 2026 to Question 109089 on Coronavirus: Research, when the UK Health Security Agency requested the report.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

Routine audit outcomes by the Prescription Medicines Code of Practice Authority are not generally published or otherwise required to be shared externally beyond the parties involved. The UK Health Security Agency (UKHSA) requested this report from Moderna in January. Whilst this has yet to be received, the UKHSA is due to meet with Moderna in the coming weeks to further understand how they are considering the findings, beyond the responses they have already provided as part of the interim case report.

Once the follow-up audit has concluded, expected in late 2026 or early 2027, the final case report and any associated outcomes will be published in accordance with the Association of the British Pharmaceutical Industry Code of Practice.